These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33215431)

  • 1. LncRNA ZFPM2-AS1 aggravates the malignant development of breast cancer via upregulating JMJD6.
    Zhao YF; Li L; Li HJ; Yang FR; Liu ZK; Hu XW; Wang Q
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11139-11147. PubMed ID: 33215431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.
    Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5675-5681. PubMed ID: 31298319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
    Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF.
    Kong F; Deng X; Kong X; Du Y; Li L; Zhu H; Wang Y; Xie D; Guha S; Li Z; Guan M; Xie K
    Oncogene; 2018 Nov; 37(45):5982-5996. PubMed ID: 29985481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA ZFPM2-AS1 Knockdown Restrains the Development of Retinoblastoma by Modulating the MicroRNA-515/HOXA1/Wnt/β-Catenin Axis.
    Lyv X; Wu F; Zhang H; Lu J; Wang L; Ma Y
    Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):41. PubMed ID: 32561925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple Cancer Types.
    Tan F
    Mini Rev Med Chem; 2023; 23(1):88-98. PubMed ID: 35578882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
    Han S; Cao D; Sha J; Zhu X; Chen D
    Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZFPM2-AS1 facilitates cell growth in esophageal squamous cell carcinoma via up-regulating TRAF4.
    Sun G; Wu C
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32065218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA TTN-AS1 promotes the metastasis in breast cancer by epigenetically activating DGCR8.
    Qiu P; Dou Y; Ma LZ; Tang XX; Liu XL; Chen JW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10835-10841. PubMed ID: 31858552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
    Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
    Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
    Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
    Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA BRE-AS1 acts as a tumor suppressor factor in bladder cancer via mediating STAT3.
    Zhang L; Liu B; Deng QH; Li JX
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5320-5328. PubMed ID: 32495865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JMJD6 induces HOTAIR, an oncogenic lincRNA, by physically interacting with its proximal promoter.
    Biswas A; Shettar A; Mukherjee G; Kondaiah P; Desai KV
    Biochem J; 2018 Jan; 475(1):355-371. PubMed ID: 29229759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
    Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
    Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
    Lee YF; Miller LD; Chan XB; Black MA; Pang B; Ong CW; Salto-Tellez M; Liu ET; Desai KV
    Breast Cancer Res; 2012 May; 14(3):R85. PubMed ID: 22621393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lncRNA AGAP2-AS1 in Breast Cancer Cell Resistance to Apoptosis by the Regulation of MTA1 Promoter Activity.
    Wu M; Wen L; Zhou Y; Wu W
    Technol Cancer Res Treat; 2022; 21():15330338221085361. PubMed ID: 35369814
    [No Abstract]   [Full Text] [Related]  

  • 18. A high level of the long non-coding RNA
    She Q; Chen Y; Liu H; Tan J; Li Y
    Bioengineered; 2022 May; 13(5):13437-13451. PubMed ID: 36700469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
    Yang J; Wu W; Wu M; Ding J
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FAM83A-AS1 aggravates the malignant development of esophageal cancer by binding to miR-495-3p.
    Huang GM; Zang HL; Geng YX; Li YH
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9408-9415. PubMed ID: 33015782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.